In our prior article, we noted that hospitals shouldn’t assume Medicaid inpatient ratios will remain stable in the years ahead. As hospitals move further away from pandemic-era Medicaid enrollment highs, the provisions taking effect in 2027 could lead to another step-down in Medicaid utilization. Hospitals that work now to determine how quickly the changes will affect inpatient days will be in a stronger position to anticipate the potential margin pressures.
Why the post-PHE backdrop still matters
To understand why the next wave of Medicaid policy changes matters, it helps to revisit what happened as Medicaid protections unwound. The Medicaid continuous enrollment provision helped drive national Medicaid and CHIP enrollment to roughly 94 million people by March 2023. After states resumed eligibility reviews and disenrollments, enrollment began to fall, declining to approximately 74.9 million by February 2026.
Coverage churn, procedural disenrollments, and lower Medicaid-covered utilization affected many markets, and more than 20 million people were disenrolled during the unwinding process. For hospitals operating near key reimbursement thresholds, the result was additional strain on Medicaid inpatient days and greater volatility in DSH-related planning.
The unwinding period demonstrated how quickly policy-driven changes in coverage can move from enrollment trends to financial reporting and strategy. Many hospitals are already working back toward more normalized Medicaid ratios. The concern is that the next set of federal changes may accelerate the trend.
The Medicaid changes hospitals should be watching in 2027
The OBBBA includes several Medicaid eligibility and administrative changes that, beginning in 2027, are expected to reduce enrollment among certain adult populations, particularly in expansion states. While implementation details will vary by state, three provisions stand out from a hospital finance perspective:
- Six-month redeterminations. States must complete eligibility redeterminations every six months, rather than every 12 months, for most adults enrolled in the Medicaid expansion group. Even if many affected individuals remain technically eligible, more frequent renewal cycles can still drive intermittent coverage disruptions and lower enrollment.
- Reduced retroactive coverage. Eligibility will be reduced from up to three months before the month of application to two months for most applicants and one month for ACA expansion adults. That shorter retroactive window could reduce the number of inpatient stays that convert to Medicaid-covered days, affecting cash collections and the number of patient days that may count toward the Medicaid fraction used in Medicare DSH calculations.
- Community engagement and work requirements. Adults in the ACA expansion population generally will need to document at least 80 hours per month of work, education, or other qualifying activity, with exemptions for certain groups. Experience from states that previously tested similar requirements suggests coverage losses may result more from reporting and documentation barriers than from actual changes in employment status. For hospitals, that means another likely source of Medicaid enrollment attrition that could eventually show up in inpatient volume.
Why this matters for Medicare DSH percentage and 340B strategy
These policy changes don’t stay confined to enrollment files. They can flow directly into the Medicaid fraction of the Medicare DSH calculation if fewer inpatient stays are covered by Medicaid or if coverage becomes less stable over time. When Medicaid inpatient volume declines, some hospitals may see a downward trend in their DSH percentage, especially if they were already operating near reimbursement or program eligibility thresholds. In other words, the greatest risk may not be the size of a hospital’s Medicaid population, but how close its DSH percentage already is to a key threshold.
It has broader implications than Medicare reimbursement alone. For 340B eligibility, the relevant DSH threshold depends on the hospital category. Most DSH hospitals must have an adjustment percentage greater than 11.75% on the most recently filed cost report, while certain hospital categories, such as rural referral centers and sole community hospitals, may qualify at a lower threshold of 8%.
However, hospitals qualifying under those lower-threshold categories are subject to different 340B rules, including the orphan drug exclusion. Hospitals also must satisfy other 340B eligibility requirements, such as hospital type, ownership or contract status, nonprofit status, and recertification requirements.
Hospitals that built their 340B strategy around pandemic-era Medicaid volume may now be exposed if they don’t actively monitor where their DSH percentage is trending. External analyses have also warned that a meaningful number of hospitals could ultimately fall below current 340B eligibility thresholds if Medicaid cuts materially reduce the volume of covered patients.
The 340B impact won’t be immediate for every hospital. Medicaid eligibility changes that reduce covered inpatient days in 2027 will first affect the cost reporting period in which those days occur. Any resulting impact on 340B eligibility will depend on when that cost report is filed and used for HRSA registration or recertification.
This risk won’t materialize in the same way for every hospital. Much will depend on state Medicaid expansion status, local labor market conditions, how aggressively the state implements new requirements, the hospital’s current margin above key DSH thresholds, and the strength of internal eligibility capture processes. But the direction of pressure is becoming clearer: If fewer patients remain enrolled in Medicaid, or if fewer inpatient encounters ultimately qualify as Medicaid-covered days, hospitals may face greater volatility in future DSH and 340B forecasting.
What hospital leaders should do now
Don’t wait for cost report results to confirm what may already be happening in your inpatient data. The hospitals best positioned will be those that start now by tracking Medicaid-covered inpatient days more frequently, identifying which populations are most exposed to redetermination and work-requirement attrition, and evaluating how a smaller retroactive coverage window could affect both collections and DSH-related day counts.
This is also the right time to revisit 340B strategy assumptions. If your organization is close to a key threshold, scenario modeling may help quantify the extent of decline in Medicaid inpatient volume that it can absorb before eligibility is at risk. The immediate goal isn’t to predict the future with precision but to build enough visibility to avoid being surprised by it. That means aligning reimbursement, finance, patient access, and data teams around a shared view of the hospital’s Medicaid volume trends and the policy changes likely to shape them over the next several years.
The post-PHE unwinding showed just how quickly Medicaid coverage changes can move from policy to operations to reimbursement impact. The OBBBA may represent the next major step in that progression. Hospitals that respond early will be in a much stronger position to protect both Medicare DSH performance and long-term 340B strategy.
